Dr. Sasha Bernatsky, MD, PhD, is a rheumatologist, epidemiologist, and James McGill Professor of Medicine at McGill University in the Divisions of Rheumatology and Clinical Epidemiology. She is a member of the Centre for Health Outcomes Research (CORE) at the Research Institute of the McGill University Health Centre and a senior scientist affiliated with the Infectious Diseases and Immunity in Global Health Program. Dr. Bernatsky is the nominated principal investigator of the CAnadian Network for Advanced Interdisciplinary Methods (CAN-AIM) team for comparative effectiveness research, a pan-Canadian research network funded by the Drug Safety and Effectiveness Network (DSEN), a collaboration between Canadian Institutes of Health Research (CIHR) and Health Canada. CAN-AIM team’s mandate is to provide new, accurate data on long-term, real-world outcomes of drug therapies. Her work on drug safety and effectiveness includes a recent national project to establish a registry of patients exposed to biosimilar agents and their legacy drugs. Dr. Bernatsky is also a mentor within the CIHR Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program, which provides a training environment for future scientists in Canada regarding high-quality post-market research in drug safety and effectiveness.